Subtopic Deep Dive
Epicardial Fat and Coronary Artery Disease
Research Guide
What is Epicardial Fat and Coronary Artery Disease?
Epicardial fat refers to the visceral adipose tissue surrounding the heart that secretes inflammatory mediators and correlates with coronary artery disease progression via CT and MRI imaging metrics.
Epicardial adipose tissue volume and composition associate with plaque burden and adverse cardiac outcomes in coronary artery disease patients. Studies using coronary CT angiography quantify epicardial fat attenuation as a biomarker of inflammation (Oikonomou et al., 2019; 464 citations). Over 10 key papers from 2003-2023, including Mazurek et al. (2003; 1921 citations), establish its pathogenic role.
Why It Matters
Epicardial fat quantification via CT improves coronary artery disease risk stratification beyond traditional scores, enabling personalized interventions (Iacobellis, 2022). Perivascular fat attenuation predicts major adverse cardiac events in CT angiography cohorts (Oikonomou et al., 2019; Goeller et al., 2018). Dapagliflozin reduces epicardial fat volume, linking SGLT2 inhibitors to adipose-mediated cardiovascular benefits (Sato et al., 2018). Inflammatory profiles in epicardial fat drive atherosclerosis locally (Mazurek et al., 2003; Baker et al., 2006).
Key Research Challenges
Quantifying Fat Composition
Distinguishing inflammatory from thermogenic components in epicardial fat requires advanced imaging like fat attenuation index (Oikonomou et al., 2019). CT and MRI metrics vary by protocol, complicating comparisons across studies. Standardization remains unresolved (Iacobellis, 2022).
Mechanistic Causality Links
Epicardial fat secretes adipocytokines promoting plaque, but causality versus association debates persist (Baker et al., 2006; Mazurek et al., 2003). Animal models lag human data on paracrine effects (Fitzgibbons and Czech, 2014). Intervention trials like dapagliflozin show volume reduction but unclear inflammation reversal (Sato et al., 2018).
Clinical Prognostic Integration
Incorporating epicardial fat metrics into risk scores needs large cohort validation (Goeller et al., 2018). Pericoronary attenuation predicts high-risk plaques in ACS but thresholds vary (Oikonomou et al., 2019). GRADE evidence levels remain moderate due to observational designs.
Essential Papers
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators
Tomasz Mazurek, Lifeng Zhang, Andrew Zalewski et al. · 2003 · Circulation · 1.9K citations
Background— Inflammatory mediators that originate in vascular and extravascular tissues promote coronary lesion formation. Adipose tissue may function as an endocrine organ that contributes to an i...
Epicardial adipose tissue in contemporary cardiology
Gianluca Iacobellis · 2022 · Nature Reviews Cardiology · 654 citations
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease
Adam Baker, Nancy F. da Silva, David W. Quinn et al. · 2006 · Cardiovascular Diabetology · 646 citations
Abstract Introduction Inflammation contributes to cardiovascular disease and is exacerbated with increased adiposity, particularly omental adiposity; however, the role of epicardial fat is poorly u...
Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease
José J. Fuster, Noriyuki Ouchi, Noyan Gokce et al. · 2016 · Circulation Research · 638 citations
Obesity is causally linked with the development of cardiovascular disorders. Accumulating evidence indicates that cardiovascular disease is the collateral damage of obesity-driven adipose tissue dy...
A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography
Evangelos K. Oikonomou, Michelle C. Williams, Christos P. Kotanidis et al. · 2019 · European Heart Journal · 464 citations
Abstract Background Coronary inflammation induces dynamic changes in the balance between water and lipid content in perivascular adipose tissue (PVAT), as captured by perivascular Fat Attenuation I...
The effect of dapagliflozin treatment on epicardial adipose tissue volume
Takao Sato, Yoshifusa Aizawa, Sho Yuasa et al. · 2018 · Cardiovascular Diabetology · 365 citations
The Role of Adipokines in Health and Disease
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco et al. · 2023 · Biomedicines · 336 citations
Adipokines are cell-signaling proteins secreted by adipose tissue that has been related to a low-grade state of inflammation and different pathologies. The present review aims to analyze the role o...
Reading Guide
Foundational Papers
Start with Mazurek et al. (2003; 1921 citations) for inflammatory mediator discovery, then Baker et al. (2006; 646 citations) for adipocytokine profiles, and Fitzgibbons and Czech (2014; 335 citations) for mechanisms.
Recent Advances
Study Iacobellis (2022; 654 citations) for cardiology overview, Oikonomou et al. (2019; 464 citations) for radiotranscriptomic FAI, and Sato et al. (2018; 365 citations) for therapeutic modulation.
Core Methods
CT volumetry and FAI from coronary angiography (Oikonomou et al., 2019); qPCR for adipokine expression (Baker et al., 2006); UCP-1 mRNA for thermogenic assessment (Sacks et al., 2009).
How PapersFlow Helps You Research Epicardial Fat and Coronary Artery Disease
Discover & Search
Research Agent uses searchPapers and exaSearch to retrieve top papers like Mazurek et al. (2003; 1921 citations) on epicardial inflammatory mediators, then citationGraph maps forward citations to Iacobellis (2022) and Oikonomou et al. (2019), while findSimilarPapers uncovers related perivascular fat studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract fat volume correlations from Sato et al. (2018), verifies claims with CoVe chain-of-verification against Mazurek et al. (2003), and runs PythonAnalysis on CT attenuation data for statistical correlations (e.g., pandas regression on FAI vs. plaque burden), assigning GRADE B evidence to prognostic claims.
Synthesize & Write
Synthesis Agent detects gaps in mechanistic studies between Baker et al. (2006) and recent interventions, flags contradictions in UCP-1 expression (Sacks et al., 2009), then Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10+ papers, with latexCompile generating figures and exportMermaid for inflammation pathway diagrams.
Use Cases
"Analyze epicardial fat volume changes in dapagliflozin trials vs. controls using meta-analysis."
Research Agent → searchPapers('dapagliflozin epicardial fat') → Analysis Agent → runPythonAnalysis(pandas meta-regression on extracted volumes from Sato et al., 2018) → outputs forest plot CSV and p-values showing 10-15% volume reduction.
"Write LaTeX review section on perivascular fat attenuation in CAD risk prediction."
Synthesis Agent → gap detection (Oikonomou 2019 vs. Goeller 2018) → Writing Agent → latexEditText(draft) → latexSyncCitations(10 papers) → latexCompile → researcher gets compiled PDF with synced bibtex and FAI threshold table.
"Find code for CT-based epicardial fat segmentation from recent papers."
Research Agent → paperExtractUrls(Oikonomou 2019) → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs Python Radiomics scripts for FAI computation validated against paper methods.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ epicardial CAD papers) → citationGraph → GRADE grading → structured report on imaging modalities. DeepScan applies 7-step analysis with CoVe checkpoints to verify Oikonomou et al. (2019) FAI prognostic claims against cohorts. Theorizer generates hypotheses on dapagliflozin's anti-inflammatory effects from Sato et al. (2018) + Baker et al. (2006).
Frequently Asked Questions
What defines epicardial fat in coronary artery disease research?
Epicardial fat is brown-like visceral adipose directly overlying myocardium, secreting inflammatory mediators like IL-6 that promote atherosclerosis (Mazurek et al., 2003).
What imaging methods quantify epicardial fat?
Coronary CT angiography measures volume and perivascular fat attenuation index (FAI); MRI assesses composition (Oikonomou et al., 2019; Iacobellis, 2022).
What are key papers on epicardial fat inflammation?
Mazurek et al. (2003; 1921 citations) showed inflammatory mediator secretion; Baker et al. (2006; 646 citations) profiled pathogenic adipocytokines in CVD patients.
What open problems exist in epicardial fat research?
Causal mechanisms need RCTs; standardizing FAI thresholds across scanners; integrating into clinical scores (Goeller et al., 2018; Iacobellis, 2022).
Research Cardiovascular Disease and Adiposity with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Epicardial Fat and Coronary Artery Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers